Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism
about
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophreniaA placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophreniaTranslational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation.Tropisetron for postoperative cognitive decline.
P2860
Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ondansetron results in improve ...... hrough a cholinergic mechanism
@ast
Ondansetron results in improve ...... hrough a cholinergic mechanism
@en
type
label
Ondansetron results in improve ...... hrough a cholinergic mechanism
@ast
Ondansetron results in improve ...... hrough a cholinergic mechanism
@en
prefLabel
Ondansetron results in improve ...... hrough a cholinergic mechanism
@ast
Ondansetron results in improve ...... hrough a cholinergic mechanism
@en
P2093
P2860
P1433
P1476
Ondansetron results in improve ...... hrough a cholinergic mechanism
@en
P2093
Karen E Stevens
Kevin S Choo
Kristin M Wildeboer
Lijun Zheng
P2860
P356
10.1016/J.BRAINRES.2009.08.075
P407
P577
2009-09-01T00:00:00Z